Edition:
India

People: CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

65.36USD
13 Dec 2019
Change (% chg)

$-0.67 (-1.01%)
Prev Close
$66.03
Open
$66.14
Day's High
$67.10
Day's Low
$64.35
Volume
205,452
Avg. Vol
217,762
52-wk High
$74.00
52-wk Low
$22.23

Kasinger, James 

Mr. James R. Kasinger J.D. serves as General Counsel, Secretary at CRISPR Therapeutics Ltd. Prior to joining our company, Mr. Kasinger served as the General Counsel and Secretary of Moderna, Inc., a biotechnology company, from April 2014 to May 2017. Prior to these roles, Mr. Kasinger was a partner at Goodwin Procter LLP, where he represented life sciences, technology and other high-growth companies. Mr. Kasinger started his legal career at Testa, Hurwitz & Thibeault. Mr. Kasinger holds a J.D. from Boston College Law School and a B.A. from Wheaton College.

Basic Compensation

Total Annual Compensation, USD 553,149
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,607,600
Fiscal Year Total, USD 3,160,750

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Rodger Novak

645,572

Samarth Kulkarni

9,727,530

Michael Tomsicek

2,253,360

Tony Ho

4,149,120

James Kasinger

3,160,750

Lawrence Klein

--
As Of  31 Dec 2018